Found: 23
Select item for more details and to access through your institution.
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 226, doi. 10.1093/neuonc/noaa191
- By:
- Publication type:
- Article
Brain metastasis detection using machine learning: a systematic review and meta-analysis.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 214, doi. 10.1093/neuonc/noaa232
- By:
- Publication type:
- Article
Extensive peritumoral edema and brain-to-tumor interface MRI features enable prediction of brain invasion in meningioma: development and validation.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 324, doi. 10.1093/neuonc/noaa190
- By:
- Publication type:
- Article
Genome-wide analysis of high-risk primary brain cancer pedigrees identifies PDXDC1 as a candidate brain cancer predisposition gene.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 277, doi. 10.1093/neuonc/noaa161
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 186, doi. 10.1093/neuonc/noaa308
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 339, doi. 10.1093/neuonc/noaa307
- Publication type:
- Article
IDH glioma radiogenomics in the era of deep learning.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 182, doi. 10.1093/neuonc/noaa294
- By:
- Publication type:
- Article
In search of predictive and response markers in antiangiogenic therapy of glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 184, doi. 10.1093/neuonc/noaa293
- By:
- Publication type:
- Article
HDACs and MYC in medulloblastoma: how do HDAC inhibitors control MYC-amplified tumors?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 173, doi. 10.1093/neuonc/noaa292
- By:
- Publication type:
- Article
Molecular classification and deconvolution of the immune microenvironment in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 175, doi. 10.1093/neuonc/noaa291
- By:
- Publication type:
- Article
Radiogenomics identifying important biological pathways in gliomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 177, doi. 10.1093/neuonc/noaa290
- By:
- Publication type:
- Article
Can proton therapy reduce radiation-related lymphopenia in glioblastoma?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 179, doi. 10.1093/neuonc/noaa273
- By:
- Publication type:
- Article
A prognostic nomogram for patients with newly diagnosed adult thalamic glioma in a surgical cohort.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 337, doi. 10.1093/neuonc/noaa268
- By:
- Publication type:
- Article
The molecular evolution of glioblastoma treated by gross total resection alone.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 334, doi. 10.1093/neuonc/noaa261
- By:
- Publication type:
- Article
The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 199, doi. 10.1093/neuonc/noaa259
- By:
- Publication type:
- Article
Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 189, doi. 10.1093/neuonc/noaa253
- By:
- Publication type:
- Article
DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 240, doi. 10.1093/neuonc/noaa247
- By:
- Publication type:
- Article
So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 295, doi. 10.1093/neuonc/noaa199
- By:
- Publication type:
- Article
Sexually dimorphic radiogenomic models identify distinct imaging and biological pathways that are prognostic of overall survival in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 251, doi. 10.1093/neuonc/noaa231
- By:
- Publication type:
- Article
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 284, doi. 10.1093/neuonc/noaa182
- By:
- Publication type:
- Article
Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 304, doi. 10.1093/neuonc/noaa177
- By:
- Publication type:
- Article
Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 314, doi. 10.1093/neuonc/noaa167
- By:
- Publication type:
- Article
A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 264, doi. 10.1093/neuonc/noaa156
- By:
- Publication type:
- Article